Prostate cancer is a malignant tumor that forms in the prostate gland of the male reproductive system. It is one of the most common types of cancer diagnosed in American men, over the age of 50. More than 200,000 new cases are diagnosed each year in the United States. As with most cancers, prostate cancer is not contagious. Recently, the overall 5-year survival rates for all stages of prostate cancer have increased from 69% to nearly 100%.
This change is a result of early detection and better treatment methods, in particular minimally invasive robotic surgery. Urologists like Dr. David Samadi have played a major part in raising awareness for the disease and saved thousands of lives by convincing men to take the PSA test.
Dr. Samadi's focus when treating prostate cancer lies in making sure his patients preserve the same quality of life as before the surgery. Erectile dysfunction or urinary incontinence are issues that men face when the prostate gland is removed surgically. This is why David Samadi's SMART technique is so appreciated: the incisions are minimal, recovery is fast and the sexual and urinary nerves are barely touched due to the precision of the robotic surgical arms.